Carbovir: the (—) enantiomer is a potent and selective antiviral agent against human immunodeficiency virus in vitro

This publication has 15 references indexed in Scilit:

• Potent and selective activity of a new carbocyclic nucleoside analog (Carbovir: NSC 614846) against human immunodeficiency virus In vitro
  Biochemical and Biophysical Research Communications, 1988
• Both 2′,3′-dideoxythymidine and its 2′,3′-unsaturated derivative (2′,3′-dideoxythymidinene) are potent and selective inhibitors of human immunodeficiency virus replication in vitro
  Biochemical and Biophysical Research Communications, 1987
• Potent and selective anti-HTLV-IIILAV activity of 2′,3′-dideoxycytidinene, the 2′,3′-unsaturated derivative of 2′,3′-dideoxycytidine
  Biochemical and Biophysical Research Communications, 1986
• Infection of HTLV-III/LAV in HTLV-I-Carrying Cells MT-2 and MT-4 and Application in a Plaque Assay
  Science, 1985
• Effects of 2′,3′‐dideoxynucleosides on mammalian cells and viruses
  Journal of Cellular Physiology, 1984
• Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDS
  Science, 1984
• Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)
  Science, 1983
• Characterization of EBV‐genome negative “null” and “T” cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non‐Hodgkin lymphoma
  International Journal of Cancer, 1977
• Establishment and characterization of a human histiocytic lymphoma cell line (U‐937)
  International Journal of Cancer, 1976
• STUDIES ON THE BIOCHEMICAL BASIS FOR THE ANTIVIRAL ACTIVITIES OF SOME NUCLEOSIDE ANALOGS^*
  Annals of the New York Academy of Sciences, 1975